Dr. Gabriel Alejandro De Erausquin's lab focuses on understanding how COVID-19 impacts cognitive decline and the risk of Alzheimer's disease among diverse populations. The research includes studying genetic variations and their relationship with cognitive health in older adults from underrepresented minorities, particularly those from America, Africa, and South America. The lab collaborates with multiple institutions to assess factors like neurological imaging and biomarkers over several years following COVID-19 infection.